The estimated Net Worth of Ray Benjamin M Anderson is at least $415 mil dollars as of 1 October 2018. Mr. Anderson owns over 1,000 units of Inogen Inc stock worth over $22,993 and over the last 11 years he sold INGN stock worth over $156,615. In addition, he makes $235,022 as Independent Director at Inogen Inc.
Sign up
Mr. Ray INGN stock SEC Form 4 insiders trading
Benjamin has made over 7 trades of the Inogen Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 4,516 units of INGN stock worth $156,615 on 3 March 2022.
The largest trade he's ever made was exercising 10,554 units of Inogen Inc stock on 25 August 2015 worth over $161,687. On average, Benjamin trades about 1,383 units every 140 days since 2014. As of 1 October 2018 he still owns at least 1,989 units of Inogen Inc stock.
You can see the complete history of Mr. Anderson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Benjamin Anderson-Ray biography
Benjamin M. Anderson-Ray is an Independent Director of Inogen, Inc. He has been a Partner and Advisor with Trinitas Advisors, a consulting firm, since 2009. Prior to joining Trinitas Advisors, he served as the Chief Executive Officer of three manufacturing companies: Hubbardton Forge, LLC from 2008 to 2009, Chromcraft Revington, Inc. from 2005 to 2008 and Gravograph New Hermes from 2002 to 2004. Prior to that, Mr. Anderson-Ray held various senior leadership roles at Sunrise Medical, Inc., a global manufacturer and distributor of durable medical equipment, including President of the Global Business Group in 2001, President of the Continuing Care Group from 1998 to 2000, and President of the Mobility Products Division from 1996 to 2001. Earlier in his career, Mr. Anderson-Ray held management and marketing roles at GE Lighting, a lighting solutions company, from 1984 to 1993, Black & Decker Home Products, a product manufacturing company, from 1993 to 1994, and Rubbermaid Home Products, a manufacturer and distributor of household items, from 1994 to 1996. He currently serves on the Board of Directors of Sommetrics, Inc. Mr. Anderson-Ray has Bachelor of Art and Science degrees in Marketing and Horticulture from Michigan State University and an M.B.A. from the University of Michigan. The Board believes that he is qualified to serve as a director of Inogen because of his leadership experience and his extensive industry experience.
What is the salary of Benjamin Ray?
As the Independent Director of Inogen Inc, the total compensation of Benjamin Ray at Inogen Inc is $235,022. There are 11 executives at Inogen Inc getting paid more, with Scott Wilkinson having the highest compensation of $2,520,530.
How old is Benjamin Ray?
Benjamin Ray is 65, he's been the Independent Director of Inogen Inc since 2013. There are no older and 19 younger executives at Inogen Inc.
What's Benjamin Ray's mailing address?
Ray's mailing address filed with the SEC is C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA, CA, 93117.
Insiders trading at Inogen Inc
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen y Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
What does Inogen Inc do?
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
What does Inogen Inc's logo look like?
Complete history of Mr. Anderson stock trades at Inogen Inc
Inogen Inc executives and stock owners
Inogen Inc executives and other stock owners filed with the SEC include:
-
Scott Wilkinson,
President, Chief Executive Officer, Director -
Alison Bauerlein,
Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer -
Bart Sanford,
Executive Vice President, Operations -
Byron Myers,
Executive Vice President of Marketing -
Brenton Taylor,
Executive Vice President - Engineering -
Dr. Stanislav Glezer M.D., MBA,
Exec. VP & CTO -
Alison Perry Bauerlein,
Co-Founder -
Bart Sanford,
Exec. VP of Operations -
Heath Lukatch,
Independent Chairman of the Board -
Heather Rider,
Independent Director -
R. Scott Greer,
Independent Director -
Loren McFarland,
Independent Director -
Benjamin Anderson-Ray,
Independent Director -
Raymond Huggenberger,
Independent Director -
Matt Bacso,
IR Contact Officer -
Scott Beardsley,
Independent Director -
Arron Retterer,
Executive Vice President of Sales -
Jennifer Yi Boyer,
Exec. VP & Chief HR Officer -
Agnes Lee,
Sr. VP of Investor Relations & Strategic Planning -
Kristin A. Caltrider,
Exec. VP, CFO & Treasurer -
Matthew Pigeon,
Investor Relations Officer -
George J. Parr,
Exec. VP & Chief Commercial Officer -
Jason Somer,
Exec. VP, Gen. Counsel & Corp. Sec. -
Matthew James Bacso C.F.A.,
Investor Relations & Corp. Devel. Mang. -
Michael K. Sergesketter,
Interim Chief Financial Officer -
Nabil Shabshab,
CEO, Pres & Director -
Kevin M King,
-
Matt Scribner,
See Remarks -
George J Parr,
Chief Commercial Officer -
William J Phd Link,
Director -
Ventures Ii Llc Versant Ven...,
-
Kristin A. Caltrider,
EVP, CFO and Treasurer -
Ventures Ii Llc Versant Ven...,
-
Ventures Ii Llclink William...,
-
Ventures Ii Lp Arboretum Ve...,
-
Stephen E. Cooper,
Director -
Ventures Ii Llc Versant Ven...,
-
Ventures Ii Llc Versant Ven...,
-
Ventures Ii Llc Versant Ven...,
-
Holdings A/S Novo,
10% owner -
Charles E Larsen,
Director -
Timothy Petersen,
Director -
Ventures Ii Llc Versant Ven...,
-
Kevin Raymond Merrill Smith,
CEO and President -
Kristen Miranda,
Director -
Nabil Shabshab,
CEO and President -
Stanislav Glezer,
EVP, R&D & Chief Med. Officer -
Jason Somer,
EVP, Gen. Counsel & Secretary -
Michael J. Bourque,
EVP, CFO & Treasurer -
Elizabeth Mora,
-
Thomas A. West,
-
Mary Kay Ladone,
-
Glenn S Boehnlein,
-
Kevin P. Smith,
EVP, Bus Dev, GC & Sec